These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 21565353

  • 21. Structural constraints imposed by the conserved fusion peptide on the HIV-1 gp41 epitope recognized by the broadly neutralizing antibody 2F5.
    de la Arada I, Julien JP, de la Torre BG, Huarte N, Andreu D, Pai EF, Arrondo JL, Nieva JL.
    J Phys Chem B; 2009 Oct 15; 113(41):13626-37. PubMed ID: 19754136
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 25. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.
    Fujii G, Horvath S, Woodward S, Eiserling F, Eisenberg D.
    Protein Sci; 1992 Nov 15; 1(11):1454-64. PubMed ID: 1303764
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach.
    Larios C, Casas J, Mestres C, Haro I, Alsina MA.
    Luminescence; 2005 Nov 15; 20(4-5):279-81. PubMed ID: 16134194
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV.
    Vishwanathan SA, Thomas A, Brasseur R, Epand RF, Hunter E, Epand RM.
    Biochemistry; 2008 Jan 08; 47(1):124-30. PubMed ID: 18081318
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M.
    Biochemistry; 2007 Apr 10; 46(14):4360-9. PubMed ID: 17371053
    [Abstract] [Full Text] [Related]

  • 35. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH, Peña LP, Tanty CR, Higginson Clarke D, Arenas MA, Noguerol KR, León CS.
    Prep Biochem Biotechnol; 2004 Aug 10; 34(3):227-37. PubMed ID: 15461139
    [Abstract] [Full Text] [Related]

  • 36. The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes.
    Mobley PW, Lee HF, Curtain CC, Kirkpatrick A, Waring AJ, Gordon LM.
    Biochim Biophys Acta; 1995 Jun 09; 1271(2-3):304-14. PubMed ID: 7605797
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of the HIV-1 fusion peptide on the mechanical properties and leaflet coupling of lipid bilayers.
    Shchelokovskyy P, Tristram-Nagle S, Dimova R.
    New J Phys; 2011 Feb 09; 13():25004. PubMed ID: 23505334
    [Abstract] [Full Text] [Related]

  • 40. A computational model for predicting fusion peptide of retroviruses.
    Wu S, Han J, Liu R, Liu J, Lv H.
    Comput Biol Chem; 2016 Apr 09; 61():245-50. PubMed ID: 26963379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.